Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Early diagnosis and teamwork are crucial for managing ILVASC effectively.

Combining laser treatment with steroid cream is more effective for alopecia areata than using the cream alone.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Tacalcitol ointment effectively improves bilateral nevus comedonicus.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Spironolactone may help reduce hair loss in androgenic alopecia.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Liver in the diet reduces cortisone acetate toxicity effects in rats.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.